Skip to main content
. Author manuscript; available in PMC: 2021 Mar 23.
Published in final edited form as: J Perinatol. 2020 Jan 31;40(6):922–927. doi: 10.1038/s41372-020-0596-2

Fig. 2. Change in AMC from baseline to illness onset, expressed as a percentage, grouped by final diagnosis (*p < 0.001).

Fig. 2

No significant AMC change from baseline is seen in infants with rule-out NEC or bacteremia without NEC. Infants with Stages 2 and 3 NEC show significant changes in AMC at the time of illness onset, relative to baseline (p < 0.001). Infants with Stage 3 NEC demonstrate a change in monocyte count that is significantly greater than the change seen in Stage 2 NEC, p < 0.001. There is a significant difference between the AMC change in rule-out NEC versus true NEC (Stages 2 or 3), p < 0.001.